Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31842
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChandrasekara, S-
dc.contributor.authorLau, E M-
dc.contributor.authorAnderson, J-
dc.contributor.authorCollins, N-
dc.contributor.authorCordina, R-
dc.contributor.authorCorrigan, C-
dc.contributor.authorDwyer, N-
dc.contributor.authorFeenstra, J-
dc.contributor.authorHorrigan, Mark-
dc.contributor.authorKeogh, A-
dc.contributor.authorKotlyar, E-
dc.contributor.authorLavender, M-
dc.contributor.authorMcWilliams, T-
dc.contributor.authorRhodes, B-
dc.contributor.authorSteele, P-
dc.contributor.authorStrange, G-
dc.contributor.authorThakkar, V-
dc.contributor.authorWeintraub, R-
dc.contributor.authorWhitford, H-
dc.contributor.authorWhyte, K-
dc.contributor.authorWilliams, T-
dc.contributor.authorWrobel, J-
dc.contributor.authorKeating, D T-
dc.date2022-
dc.date.accessioned2023-01-12T04:50:28Z-
dc.date.available2023-01-12T04:50:28Z-
dc.date.issued2023-02-08-
dc.identifier.citationHeart, Lung and Circulation (2023) 32, 156–165en_US
dc.identifier.issn1444-2892-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31842-
dc.description.abstractPulmonary arterial hypertension (PAH) has a progressive, unremitting clinical course. Vasoreactivity testing (VdT) during right heart catheterisation (RHC) identifies a subgroup with excellent long-term response to calcium channel blockade (CCB). Reporting on these patients is limited. Established in 2011, the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) registry offers the opportunity to assess the frequency of VdT during RHC, treatment and follow up of PAH patients.en_US
dc.language.isoeng-
dc.subjectCalcium channel blockersen_US
dc.subjectPulmonary hypertensionen_US
dc.subjectRight heart catheteren_US
dc.subjectRight ventricular failureen_US
dc.subjectVasoreactivity testingen_US
dc.titleAcute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleHeart, Lung & Circulationen_US
dc.identifier.affiliationSchool of Medicine, University of Notre Dame, Fremantle, WA, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.en_US
dc.identifier.affiliationSchool of Medicine, University of Notre Dame, Fremantle, WA, Australiaen_US
dc.identifier.affiliationPulmonary Hypertension Society of Australia and New Zealand.en_US
dc.identifier.affiliationDepartment of Clinical Medicine, Macquarie University, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Rheumatology, Liverpool Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationRoyal Children's Hospital, Melbourne, Vic, Australiaen_US
dc.identifier.affiliationMurdoch Children's Research Institute, Melbourne, Vic, Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, Melbourne, Vic, Australia.en_US
dc.identifier.affiliationAdvanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australiaen_US
dc.identifier.affiliationSydney Medical School, University of Sydney, Sydney, NSW, Australia.en_US
dc.identifier.affiliationRespiratory Department, Sunshine Coast University Hospital, Birtinya, Qld, Australia.en_US
dc.identifier.affiliationDepartment of Cardiology, John Hunter Hospital, Newcastle, NSW, Australia.en_US
dc.identifier.affiliationDepartment of Cardiology, Royal Prince Alfred Hospital, and Heart Research Institute, Sydney, NSW, Australia.en_US
dc.identifier.affiliationHeart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationDepartment of Cardiology, Royal Hobart Hospital, Hobart, Tas, Australia.en_US
dc.identifier.affiliationQueensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Qld, Australia.en_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.affiliationHeart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationHeart and Lung Transplant Unit, St Vincent's Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationAdvanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia.en_US
dc.identifier.affiliationGreenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Christchurch Hospital, Christchurch, New Zealand.en_US
dc.identifier.affiliationDepartment of Cardiovascular Services, Royal Adelaide Hospital, Adelaide, SA, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.en_US
dc.identifier.affiliationGreenlane Clinical Centre, Auckland City Hospital, Auckland, New Zealand.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Vic, Australia.en_US
dc.identifier.doi10.1016/j.hlc.2022.09.005en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36503731-
local.name.researcherChung, William
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptCardiology-
crisitem.author.deptVictorian Liver Transplant Unit-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Jan 2, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.